VZV ORF26

Varicella Zoster Virus ORF26 Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Interactions and Role in Replication

ORF26 is a central hub in the VZV protein interaction network, linking DNA packaging and nuclear egress. Key findings include:

Terminase Complex Assembly

ORF26 interacts with ORF25 (UL33 homolog), ORF30 (UL28 homolog), and ORF45/42 (UL15 homolog) to form the terminase complex. This complex cleaves concatemeric viral DNA and packages it into capsids .

Nuclear Egress Coordination

ORF26 interacts with nuclear egress complex (NEC) components, including ORF24 (UL34 homolog) and ORF27 (UL31 homolog), facilitating capsid transport from the nucleus to the cytoplasm .

Interaction PartnerDetection MethodBiological Relevance
ORF25Y2H, LuMPIS, BRET Terminase complex formation
ORF27Y2H, LuMPIS, BRET Nuclear egress complex integration
ORF30Y2H, LuMPIS, BRET DNA packaging and cleavage

Recombinant VZV ORF26 Applications

Recombinant ORF26 is widely used in research for functional and immunological studies:

ProductDetails
SourceE. coli (GST fusion)
Epitopesa.a. 9-33; 184-208 (immunodominant regions)
Purity>90% (SDS-PAGE verified) ; >95% (Bradford assay)
ApplicationsELISA, Western blot, flow-through assays

This recombinant protein reacts strongly with VZV-positive human serum, enabling diagnostic and vaccine development research .

Research Implications

ORF26’s essential role in viral replication highlights its potential as a therapeutic target. Studies using knockout mutants and interaction mapping provide insights into:

  • Antiviral Strategies: Disrupting ORF26 interactions could impair DNA packaging/nuclear egress.

  • Vaccine Development: Recombinant ORF26 may enhance immune recognition of VZV.

Product Specs

Introduction
Varicella-zoster virus (VZV) is closely related to the herpes simplex viruses (HSV), sharing significant genome homology. Both viruses possess similar envelope glycoproteins, including gB, gC, gE, gH, gI, gK, and gL. However, VZV lacks an equivalent to HSV gD. VZV virions exhibit a spherical shape with a diameter ranging from 150 to 200 nm. Their lipid envelope encapsulates a nucleocapsid composed of 162 capsomeres arranged in a hexagonal pattern. The viral DNA consists of a single, linear, double-stranded molecule with a length of 125,000 nucleotides. VZV is highly susceptible to disinfectants, particularly sodium hypochlorite. Effective treatments for VZV infection include antiviral drugs like acyclovir, vidarabine, and immunotherapies such as zoster immune globulin (ZIG).
Description
This recombinant protein is derived from E. coli and contains the immunodominant regions of VZV ORF26, specifically amino acids 9-33 and 184-208.
Purity
The purity of the Varicella protein exceeds 95%, as determined by 10% PAGE (coomassie staining).
Formulation
The Varicella protein is supplied in a buffer consisting of 25mM Tris-Hcl pH 7.2, 1mM EDTA, and 50% glycerol.
Stability
For optimal stability, the Varicella protein should be stored below -18°C. While it can remain stable at 4°C for up to one week, it is recommended to avoid repeated freeze-thaw cycles.
Applications
The Varicella Zoster antigen is well-suited for use in ELISA and Western blots. Its exceptional purity and specificity make it an excellent antigen for the detection of VZV with minimal cross-reactivity.
Source
Escherichia Coli.
Purification Method

Varicella was purified by proprietary chromatographic technique.

Specificity
Immunoreactive with sera of VZV-infected individuals.

Q&A

What is VZV ORF26 and what is its role in the viral life cycle?

VZV ORF26 is one of at least 70 genes encoded by the varicella-zoster virus genome. While specific details about ORF26's exact function remain under investigation, it is among the structural proteins of the virus that has been analyzed in various immunological and transcriptomic studies. The VZV genome contains multiple ORFs with varying functions in viral replication, latency, and pathogenesis . ORF26p (the protein encoded by ORF26) was among the VZV proteins selected for analysis in antibody studies due to its established biological function in the viral life cycle .

How does ORF26 expression change during different phases of VZV infection?

The expression of ORF26, like other VZV genes, follows a relatively orderly cascade of gene expression during lytic infection. VZV genes are categorized as immediate early (regulatory), early, and late (structural) genes. Advanced transcriptomic studies using long-oligonucleotide-based microarrays have mapped the global pattern of VZV gene transcription, which includes ORF26 . Recent analyses using multiple short-read RNA sequencing approaches with long-read direct RNA sequencing have further decoded the complex architecture of the VZV transcriptome, allowing researchers to better understand the temporal expression patterns of individual ORFs, including ORF26 .

What methodologies can be used to detect ORF26 expression in VZV-infected cells?

Several methodological approaches are available for detecting ORF26 expression:

  • RNA Sequencing Techniques: Both short-read and long-read direct RNA sequencing have been employed to characterize the VZV transcriptome, including ORF26 expression .

  • Microarray Analysis: VZV microarrays using 75-base oligomers specific to VZV ORFs have been designed to study the global pattern of gene transcription with high stringency and polarity .

  • RT-PCR: Reverse transcription-polymerase chain reaction can be used to detect and quantify ORF26 mRNA from infected cells, similar to approaches used for other VZV ORFs .

  • Protein Detection Methods: Antibody-based techniques have been developed to detect ORF26p, where the protein was successfully analyzed in immunological studies .

How can researchers conduct knockout or mutation studies of ORF26?

Advanced genetic manipulation of VZV ORF26 can be approached using several established techniques:

  • Cosmid and BAC Systems: Cosmids and Bacterial Artificial Chromosomes (BACs) corresponding to VZV parental Oka and vaccine Oka viruses have been successfully used to "knock-out" 34 VZV genes in previous studies. This methodology allows for precise genetic manipulation of specific ORFs, including ORF26 .

  • Site-Directed Mutagenesis: Researchers can introduce specific mutations within the ORF26 sequence to examine the functional consequences on protein activity and viral replication.

  • Complementation Assays: If ORF26 proves essential for viral replication, complementation systems can be developed where the gene is expressed in trans to rescue viral growth.

  • CRISPR-Cas9 Approaches: While not explicitly mentioned in the search results, modern genome editing techniques could potentially be adapted for more precise manipulation of the VZV genome including ORF26.

When designing knockout studies, researchers should note that seven VZV genes (ORF4, 5, 9, 21, 29, 62, and 68) have been shown to be required for growth in vitro . The essentiality of ORF26 would need to be empirically determined.

What are the challenges in expressing recombinant ORF26 protein for structural studies?

Producing recombinant ORF26 protein presents several methodological challenges:

  • Expression Systems: Various systems have been employed for VZV protein expression. For instance, when studying VZV antigens, some proteins were purchased commercially while others required specialized expression methods such as the Assembly PCR and cell-free in vitro Wheat Germ Protein Expression System .

  • Protein Purification: Establishing effective purification protocols for ORF26p requires consideration of protein characteristics such as solubility, stability, and potential post-translational modifications.

  • Functional Validation: Confirming that recombinantly expressed ORF26p retains its native structure and function is essential for meaningful structural studies.

  • Crystallization Challenges: For X-ray crystallography studies, optimizing conditions for ORF26p crystallization would require systematic screening of various parameters.

How does RNA sequencing data inform our understanding of ORF26 transcription?

Recent advanced RNA sequencing approaches have significantly expanded our understanding of the VZV transcriptome architecture, including ORF26:

  • Integrated Approach: Studies have combined multiple short-read RNA sequencing methods with long-read direct RNA sequencing on RNA isolated from VZV-infected cells .

  • Transcriptional Mapping: Mapping of transcription start sites, splice junctions, and polyadenylation sites has identified 136 distinct polyadenylated VZV RNAs encoding canonical ORFs, noncanonical ORFs, and ORF fusions .

  • Temporal Expression Patterns: RNA sequencing data can reveal when during the viral life cycle ORF26 is expressed, providing insights into its potential function.

  • Alternative Transcripts: The complexity of the VZV transcriptome revealed by sequencing studies suggests potential alternative transcripts or overlapping RNAs that include ORF26, which could have regulatory implications.

What methodological considerations are important when analyzing ORF26 transcription using microarrays?

When employing microarray technology to study ORF26 transcription, researchers should consider:

  • Oligonucleotide Design: Probes should be designed with specific parameters, as demonstrated in previous studies using 75-base oligomers. Design specifications may include 85–95°C melting temperature, appropriate ΔG values, and 45–55% GC content .

  • Control Elements: Microarrays should include appropriate controls such as probes for cellular housekeeping genes, negative control probes (unrelated genes), and printing vehicle without nucleic acids .

  • Normalization: Data normalization is crucial and can be achieved by normalizing to a subset of invariant ranked host-encoded positive-control genes .

  • Statistical Analysis: Robust formal statistical analysis should be applied to microarray data to ensure reliable results.

  • Validation: Confirming microarray results using independent methods such as RT-PCR is essential for verifying ORF26 expression patterns .

How can researchers determine if ORF26p interacts with host cellular proteins?

Several methodological approaches can be employed to investigate potential interactions between ORF26p and host cellular proteins:

  • Co-immunoprecipitation (Co-IP): This technique can identify protein-protein interactions by using antibodies to precipitate ORF26p along with any interacting partners.

  • Yeast Two-Hybrid Screening: This system can be used to screen for potential protein interactions between ORF26p and libraries of host cellular proteins.

  • Protein Microarrays: Arrays containing host cellular proteins can be probed with labeled ORF26p to identify binding partners.

  • Proximity Labeling: Methods such as BioID or APEX can identify proteins in close proximity to ORF26p within the cellular environment.

  • Functional Assays: Specific cellular pathway activation or inhibition in the presence of ORF26p can reveal functional interactions with host systems.

What approaches are effective for studying ORF26p's role in viral pathogenesis?

Investigating ORF26p's role in VZV pathogenesis requires multiple complementary approaches:

  • In Vitro Infection Models: Studies using different cell types can reveal cell-specific effects of ORF26. For example, studies have shown differences in VZV gene expression between MeWo and SVG cells .

  • Animal Models: While the experimental approach to VZV infection has been limited by the lack of an animal model in which VZV can be reactivated, latent infection has been established in guinea pig enteric nervous system through various methods, which could potentially be used to study ORF26 function .

  • Genetic Manipulation: Creating recombinant viruses with mutations in ORF26 can help determine its role in viral infection and pathogenesis. VZV genomes have been successfully manipulated using cosmids and BACs .

  • Immunological Studies: Examining host immune responses to ORF26p can provide insights into its role during infection. Previous studies have analyzed antibody responses to specific VZV proteins including ORF26p .

How should researchers interpret contradictory data about ORF26 function?

When facing contradictory results regarding ORF26 function, consider these methodological approaches:

  • Cell Type Considerations: VZV exhibits different behaviors in different cell types. For example, in neuronal models, VZV can establish latency when neurons are exposed to cell-free VZV, but infection becomes lytic when fibroblasts are present .

  • Temporal Analysis: The function of ORF26 may differ depending on the stage of infection being studied (immediate early, early, or late phases).

  • Technical Validation: Employ multiple independent techniques to verify observations. For instance, microarray findings should be validated using RT-PCR and/or in situ hybridization .

  • Statistical Rigor: Ensure proper statistical analysis is applied to experimental data, as exemplified in studies of VZV protein antibody correlations where statistical significance was carefully assessed .

  • Experimental Controls: Include appropriate positive and negative controls in all experiments to accurately interpret results.

What are common pitfalls in analyzing ORF26p expression and how can they be avoided?

Several technical challenges may arise when studying ORF26p expression:

  • Antibody Specificity: Ensure antibodies used for ORF26p detection are highly specific, as cross-reactivity with other viral or cellular proteins can lead to misinterpretation of results.

  • Signal Saturation: Avoid over-saturation in fluorescence-based detection methods, which was observed with some VZV proteins in antibody studies where values clustered at the upper limits of photomultiplier detection .

  • Normalization Approaches: Properly normalize expression data, particularly when comparing ORF26 expression across different conditions or cell types.

  • RNA Quality: Ensure high-quality RNA extraction for transcriptomic studies, as degraded RNA can significantly impact results.

  • Temporal Dynamics: Consider the dynamic nature of VZV gene expression during the viral life cycle when designing experimental time points.

How might single-cell transcriptomics advance our understanding of ORF26 expression?

Single-cell transcriptomics represents a promising frontier for understanding ORF26 expression patterns:

  • Cellular Heterogeneity: Single-cell approaches could reveal potential heterogeneity in ORF26 expression across individual infected cells that might be masked in bulk analyses.

  • Temporal Resolution: With appropriate experimental design, single-cell methods could provide improved temporal resolution of ORF26 expression during the viral life cycle.

  • Co-expression Patterns: These methods could identify co-expression relationships between ORF26 and other viral or host genes at the single-cell level.

  • Latency Insights: Single-cell approaches might help distinguish between lytic and latent infection states at the cellular level, providing context for ORF26 expression patterns.

What are the most promising approaches for determining the structural biology of ORF26p?

Advanced structural biology techniques offer opportunities to elucidate ORF26p's structure and function:

  • Cryo-Electron Microscopy: This technique could potentially determine the structure of ORF26p either in isolation or as part of larger viral complexes.

  • X-ray Crystallography: With appropriate expression and purification systems, crystallographic studies could reveal the atomic structure of ORF26p.

  • NMR Spectroscopy: For smaller domains of ORF26p, NMR could provide structural insights and information about dynamic properties.

  • Integrative Structural Biology: Combining multiple structural techniques with computational modeling could yield comprehensive structural models of ORF26p.

  • Structure-Function Studies: Correlating structural features with functional assays would provide mechanistic insights into ORF26p's role in the viral life cycle.

Product Science Overview

Introduction to Varicella Zoster Virus (VZV)

Varicella Zoster Virus (VZV), also known as Human Herpesvirus 3 (HHV-3), is a member of the genus Varicellovirus in the Alphaherpesvirinae subfamily of the Herpesviridae family . VZV is the causative agent of chickenpox (varicella) in children and shingles (zoster) in adults. After the primary infection, the virus establishes latency in the sensory ganglia and can reactivate later in life to cause shingles .

Structure and Genome of VZV

The VZV genome is approximately 125 kilobases (kb) of linear double-stranded DNA containing around 71 open reading frames (ORFs) . The viral structure is similar to other alphaherpesviruses, consisting of two unique regions, unique long (UL) and unique short (US), each flanked by inverted repeats . The genome organization includes terminal repeat long (TRL) and internal repeat long (IRL) bordering the UL region, and terminal repeat short (TRS) and internal repeat short (IRS) bordering the US region .

ORF26 in VZV

ORF26 is one of the 71 ORFs in the VZV genome. It encodes a protein that is part of the viral tegument, which is a layer of proteins located between the viral envelope and the nucleocapsid . The ORF26 protein is known to be immunodominant, meaning it elicits a strong immune response in the host .

Recombinant VZV ORF26 Protein

Recombinant VZV ORF26 protein is produced by expressing the ORF26 gene in a bacterial system, such as Escherichia coli (E. coli), and purifying the protein using chromatographic techniques . The recombinant protein typically contains the immunodominant regions of the ORF26 protein, specifically amino acids 9-33 and 184-208 . This recombinant protein is used in various research and diagnostic applications, including the generation of antibodies that specifically target the ORF26 protein .

Applications of Recombinant VZV ORF26 Protein

The recombinant VZV ORF26 protein is valuable in several areas of research and diagnostics:

  • Immunization Protocols: It is used to generate antibodies that specifically target the ORF26 protein, which can be used in various immunological assays .
  • Diagnostic Tools: The recombinant protein can be used in diagnostic tests to detect the presence of VZV-specific antibodies in patient samples .
  • Vaccine Development: Research on the ORF26 protein can contribute to the development of vaccines against VZV .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.